These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12054172)

  • 41. COX-2 inhibitors.
    Tustin T
    Lancet; 1999 Apr; 353(9162):1439; author reply 1440. PubMed ID: 10227242
    [No Abstract]   [Full Text] [Related]  

  • 42. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).
    Oshima M; Dinchuk JE; Kargman SL; Oshima H; Hancock B; Kwong E; Trzaskos JM; Evans JF; Taketo MM
    Cell; 1996 Nov; 87(5):803-9. PubMed ID: 8945508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SAR in the alkoxy lactone series: the discovery of DFP, a potent and orally active COX-2 inhibitor.
    Leblanc Y; Roy P; Boyce S; Brideau C; Chan CC; Charleson S; Gordon R; Grimm E; Guay J; Léger S; Li CS; Riendeau D; Visco D; Wang Z; Webb J; Xu LJ; Prasit P
    Bioorg Med Chem Lett; 1999 Aug; 9(15):2207-12. PubMed ID: 10465547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of recombinant human cyclooxygenase isoenzymes in transfected COS-7 cells in vitro and inhibition by tenoxicam, indomethacin and aspirin.
    Lora M; Morisset S; Ménard HA; Leduc R; de Brum-Fernandes AJ
    Prostaglandins Leukot Essent Fatty Acids; 1997 May; 56(5):361-7. PubMed ID: 9175172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Renal effects of selective cyclooxygenase inhibition in experimental liver disease.
    López-Parra M; Clària J; Planagumà A; Titos E; Masferrer JL; Woerner BM; Koki AT; Jiménez W; Arroyo V; Rivera F; Rodés J
    Adv Exp Med Biol; 2003; 525():133-6. PubMed ID: 12751752
    [No Abstract]   [Full Text] [Related]  

  • 46. Novel inhibitors of cyclooxygenase-2: the sulfones and sulfonamides of 1,2-diaryl-4,5-difluorobenzene. Analysis of quantitative structure-activity relationship.
    Singh P; Kumar R
    J Enzyme Inhib; 1998 Sep; 13(6):409-17. PubMed ID: 9825305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclooxygenase 2 selective inhibitors: panacea or flash in the pan?
    Beejay U; Wolfe MM
    Gastroenterology; 1999 Oct; 117(4):1002-5. PubMed ID: 10500082
    [No Abstract]   [Full Text] [Related]  

  • 48. COX-2 inhibitors.
    Russell RI
    Lancet; 1999 Apr; 353(9162):1439-40. PubMed ID: 10227243
    [No Abstract]   [Full Text] [Related]  

  • 49. Synthesis and biological evaluation of 3-heteroaryloxy-4-phenyl-2(5H)-furanones as selective COX-2 inhibitors.
    Lau CK; Brideau C; Chan CC; Charleson S; Cromlish WA; Ethier D; Gauthier JY; Gordon R; Guay J; Kargman S; Li CS; Prasit P; Riendeau D; Thérien M; Visco DM; Xu L
    Bioorg Med Chem Lett; 1999 Nov; 9(22):3187-92. PubMed ID: 10576685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and biological evaluation of 1,3,4-triaryl-3-pyrrolin-2-ones, a new class of selective cyclooxygenase-2 inhibitors.
    Bosch J; Roca T; Catena JL; Llorens O; Pérez JJ; Lagunas C; Fernández AG; Miquel I; Fernández-Serrat A; Farrerons C
    Bioorg Med Chem Lett; 2000 Aug; 10(15):1745-8. PubMed ID: 10937738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pyrogenic cytokines injected into the rat cerebral ventricle induce cyclooxygenase-2 in brain endothelial cells and also upregulate their receptors.
    Cao C; Matsumura K; Shirakawa N; Maeda M; Jikihara I; Kobayashi S; Watanabe Y
    Eur J Neurosci; 2001 May; 13(9):1781-90. PubMed ID: 11359529
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells.
    Goel A; Boland CR; Chauhan DP
    Cancer Lett; 2001 Oct; 172(2):111-8. PubMed ID: 11566484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclooxygenase 2 induction: molecular mechanism and pathophysiologic roles.
    Wu KK
    J Lab Clin Med; 1996 Sep; 128(3):242-5. PubMed ID: 8783630
    [No Abstract]   [Full Text] [Related]  

  • 54. Analysis of cyclooxygenase-substrate interactions using stereospecifically-labeled arachidonic acids.
    Schneider C; Boeglin WE; Brash AR
    Adv Exp Med Biol; 2002; 507():49-53. PubMed ID: 12664563
    [No Abstract]   [Full Text] [Related]  

  • 55. Cyclooxygenase-2 inhibitor inhibits the fracture healing.
    Endo K; Sairyo K; Komatsubara S; Sasa T; Egawa H; Yonekura D; Adachi K; Ogawa T; Murakami R; Yasui N
    J Physiol Anthropol Appl Human Sci; 2002 Sep; 21(5):235-8. PubMed ID: 12491820
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and activity of sulfonamide-substituted 4,5-diaryl thiazoles as selective cyclooxygenase-2 inhibitors.
    Carter JS; Kramer S; Talley JJ; Penning T; Collins P; Graneto MJ; Seibert K; Koboldt CM; Masferrer J; Zweifel B
    Bioorg Med Chem Lett; 1999 Apr; 9(8):1171-4. PubMed ID: 10328307
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclooxygenase (COX) function in the ductus arteriosus: another look.
    Coceani F; Baragatti B; Brizzi F; Barogi S; Ackerley C
    Adv Exp Med Biol; 2003; 525():193-6. PubMed ID: 12751766
    [No Abstract]   [Full Text] [Related]  

  • 58. Cyclo-oxygenase-2 and renal function.
    Krämer BK
    Nephrol Dial Transplant; 2001 Jan; 16(1):180-3. PubMed ID: 11209021
    [No Abstract]   [Full Text] [Related]  

  • 59. A cyclooxygenase-2 inhibitor attenuates white matter damage in chronic cerebral ischemia.
    Wakita H; Tomimoto H; Akiguchi I; Lin JX; Miyamoto K; Oka N
    Neuroreport; 1999 May; 10(7):1461-5. PubMed ID: 10380963
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia.
    Nakayama M; Uchimura K; Zhu RL; Nagayama T; Rose ME; Stetler RA; Isakson PC; Chen J; Graham SH
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10954-9. PubMed ID: 9724811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.